MedTrace Logo

Impact of an Intensified Thromboprofylaxis Protocol in COVID-19

NCT04394000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2020-05-19

No results posted yet for this study

Summary

The aim of this study is to investigate and compare the mortality, the incidence of DVT and the incidence of kidney and liver failure in patients admitted to the ICU before and after the implementation of an intensified thromboprofylaxis protocol on 31st of March 2020. Patients in the before group are admitted at the ICU from 13/3/2020-30/3/2020 and patients in the after group are admitted to the ICU from 31/3 until 20/4/2020.

Conditions

  • COVID19
  • Thromboembolism

Interventions

OTHER

thromboprofylaxis protocol

This individualised protocol contains three cornerstones: an increase in dosage of prophylactic LMWH close to therapeutic doses, introduction of routine venous ultrasonography and daily measurements of plasma anti-factor Xa activity

OTHER

standard protocol

This protocol contains a routine low dose pharmacological venous thromboembolism (VTE) prophylaxis with LMWH

Sponsors & Collaborators

  • Jessa Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-04
Primary Completion
2020-05-15
Completion
2020-05-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394000 on ClinicalTrials.gov